IMPORTANCE Black patients with advanced osteoarthritis (OA) of the knee are significantly less likely than white patients to undergo surgery. No strategies have been proved to improve access to surgery for black patients with end-stage OA of the knee.
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; these limitations as well as the burden of severe pain disproportionately affect black patients. 2 The prevalence of OA among older black individuals is at least as high as that reported for white individuals, 3, 4 and OA is among the leading causes of disability, particularly for the elderly, in the United States. [5] [6] [7] [8] [9] [10] [11] [12] [13] Total knee replacement (TKR) is the most effective and cost-effective surgical option for moderate to severe OA of the knee. 14 However, a significant racial variation in the use of TKR exists. Black patients are less likely to undergo TKR compared with white patients 11, [15] [16] [17] despite the fact that black patients have similar prevalence or severity of OA of the knee, 18, 19 report a lower quality of life, 20 and have higher odds of disability 21 due to OA.
Black candidates for joint replacement differ in their preferences for treatment, which are primarily shaped by differences in understanding of treatment risks and benefits. 22 Lower patient preference for the treatment reduces patient likelihood of receiving a recommendation for joint replacement from an orthopedic surgeon, even when clinically indicated. 23 Furthermore, a patient-centered educational intervention using a decision aid for OA of the knee significantly increases black patients' knowledge about TKR and consequently improves their willingness to undergo the treatment if clinically indicated and recommended by a physician. 24 Whether a decision aid actually improves receipt of joint replacement and/or a recommendation for surgery from an orthopedic surgeon remains unclear. Therefore, in this randomized clinical trial, we tested whether a decision aid for OA of the knee, a source of evidence-based information about the management of knee OA, actually improves access to the surgery for black patients who are referred to orthopedic surgery and are clinically appropriate candidates for TKR.
Methods

Design Overview
The study methods and recruitment process were described previously. 25 In brief, this randomized clinical trial compared the effects of a decision aid for OA of the knee (intervention) with receipt of an OA education booklet (control condition) in persons with moderate-to-severe OA of the knee. Participants were randomized at baseline to the intervention or the control group (Figure 1) . The study protocols (available in the Supplement) were approved by the institutional review boards of the University of Pennsylvania, Philadelphia, Temple University Health System, Philadelphia, and the Philadelphia Veterans Affairs Medical Center. All participants provided written informed consent before the study and were compensated for their time and participation.
Setting and Participants
Participants were recruited from December 1, 2010, to May 31, 2014. Potentially eligible participants were identified by screening the electronic medical records of patients referred to the orthopedic surgery clinic at any of the 3 study sites.
All identified persons underwent assessment for study eligibility by telephone interview. Eligible participants were those who self-identified as black, were 50 years or older, had chronic and frequent knee pain based on the National Health and Nutrition Examination Survey questionnaire, 26 had a Western Ontario McMaster Universities Osteoarthritis Index (WOMAC) score 27 of at least 39 (range, 0-100, with
Key Points
Question Does patient education with a decision aid improve access to total knee replacement surgery for black patients with end-stage osteoarthritis of the knee?
Findings In this randomized clinical trial of 336 individuals, a patient-centered educational intervention using validated decision aid significantly increased receipt of total knee replacement surgery for black patients with end-stage osteoarthritis of the knee.
Meaning Patient-centered educational tools such as decision aids might help reduce racial disparities in access to preferencesensitive surgical treatments such as total knee replacement. higher scores indicating increased pain, stiffness, and functional limitations), and had radiographic evidence of OA of the knee. Exclusion criteria consisted of a history of major joint replacement, diagnosis of a terminal illness (eg, endstage cancer), physician diagnosis of inflammatory arthritis (ie, rheumatoid arthritis, connective tissue disease, ankylosing spondylitis, or other seronegative spondyloarthropathy), contraindications to replacement surgery (eg, lower extremity paralysis as a result of stroke), having a prosthetic leg, cognitive impairment (eg, dementia), and not having home telephone service.
Randomization and Intervention
Participants were randomized to one of the 2 study arms using a computer-generated assignment. The computer-generated randomization result was sent to the study coordinator via email before the scheduled intervention session. Owing to the nature of the intervention, participants could not have been blinded to the study arm to which they were randomized. The orthopedic surgeons were blinded to patient randomization.
Control Group
Participants randomly assigned to the control group received an educational booklet developed by the National Institute of Arthritis and Musculoskeletal and Skin Diseases 28 that summarizes how to live with knee OA but does not mention joint replacement. The purpose of the booklet was to offer patients some benefit in participating in the study.
Intervention Group
This study used the patient decision aid for OA of the knee developed by the Foundation for Informed Medical Decision Making as a vehicle to deliver high-quality, relevant, and timely information on knee OA and joint replacement. The decision aid consists of a 40-minute video that discusses treatment options, including lifestyle changes, medications, injections, complementary therapy, and surgery. The risks, benefits, and known efficacy of each treatment option are outlined. Clinical indications, operative duration, hospital duration, the need for rehabilitative care and physical therapy, recovery time and effort, and cost are also covered. The risks of knee replacement surgery, including death, how long a single prosthesis lasts, and consideration of whether to have both knees replaced at the same time or one at a time are discussed.
Outcome Measures
The clinical outcome of interest was receipt of TKR within 12 months after viewing the video and/or receipt of a recommendation for surgery from an orthopedic surgeon within 6 months of viewing the video. Research staff who were not involved in the intervention and were blinded to the study arm abstracted this information from the medical record.
Covariates
At baseline, participants were asked about their willingness to undergo TKR if recommended by the surgeon. Response options ranged from definitely not willing to definitely willing in a 5-category ordinal response scale. Sociodemographic characteristics, including age, sex, educational attainment, employment status, annual household income, marital status, and living situation, were also assessed at baseline. Severity of knee OA was assessed using the WOMAC index. 27 Two subscales of the Arthritis Self-efficacy Scale were also reported. 29 The pain subscale measures patients' confidence that they can manage arthritis-related pain (range, 5-50, with higher scores indicating more confidence), and the function subscale measures patients' confidence that they can perform specific daily activities (range, 9-90, with higher scores indicating more confidence). Medical comorbidity was assessed using an interviewer-based modification of the Charlson Comorbidity Index (range, 0-17, with higher scores indicating greater comorbidities). 30, 31 Overall quality of life was assessed using the 12-Item Short Form Health Survey, version 2, from which the physical and mental component summary scores were calculated (range, 12-61 for the physical and 22-70 for the mental components, with higher scores indicating better physical and mental health).
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Statistical Analysis
Analyses were performed on a per-protocol basis, including patients who actually received the intervention, and an intentionto-treat (ITT) basis, in which all randomized participants, whether or not they viewed the decision aid video for knee OA. Demographic and clinical characteristics were compared by intervention vs control groups using 2-tailed t tests for continuous variables and χ 2 for categorical variables.
In our primary analysis, the clinical outcome of interest was the recommendation for TKR by an orthopedic surgeon at 6 months after the intervention and/or receipt of TKR surgery at 12 months after the intervention. This information was assessed separately, comparing the intervention and the control arms. Because of our ability to extract data for clinical outcome using the electronic medical record, we had complete data for all study participants regardless of whether they received the intended intervention.
Because the study participants were recruited from 3 different hospital systems in Philadelphia, we used logistic regression analysis to examine the effect of the intervention on a recommendation for TKR within 6 months or receipt of TKR within 12 months. We first estimated the unadjusted (crude) odds ratio (OR) for each outcome. We then added into the model the site of care as a covariate. We reported results from both analyses.
Finally, we conducted additional exploratory analyses to assess whether particular subgroups of patients might benefit from the intervention to a greater degree than others. We postulated that patients might derive more or less benefit from the intervention based on sex, age, patient willingness at baseline, and disease-severity level. Accordingly, we used logistic regression models to evaluate the association between each of these patient variables and the 2 study outcomes separately to compare the intervention and control groups with site of care as an additional covariate. We included an interaction term for each variable with the treatment group to test for evidence of effect modification by each of the variables of interest. We report the P value for the interaction term, along with
Results
Participants and Baseline Characteristics
A total of 2194 individuals underwent assessment for the study (Figure 1 ). Of these, 1542 persons declined or were unable to be contacted for full screening, and 652 underwent full screening for the study. Of these, 312 individuals were ineligible. The remaining 340 participants consented to the study and underwent baseline (prerandomization) assessments of clinical and demographic characteristics as fully eligible. Four participants withdrew from the study after baseline assessments. years), 168 were randomized to the intervention (decision aid) arm and 168 to the control arm. Among those randomized to the intervention arm, 150 completed the intervention entirely. The rest did not receive the video intervention. Of those assigned to the control arm, 14 were unavailable for telephone follow-up. However, information on key clinical outcomes for all participants was abstracted from the medical record for full analysis (CONSORT diagram in Figure 1 ). Baseline participant clinical and demographic characteristics are summarized in the Table. Overall, we found no statistically significant differences in demographic or clinical characteristics between the intervention and control arms.
Primary Outcomes
In the ITT analysis, 13 of 168 controls (7.7%) and 25 of 168 intervention patients (14.9%) underwent TKR within 12 months of the intervention (P = .04). This result represents a 70% increase in the receipt of TKR for the intervention group. For the per-protocol sample, receipt of surgery increased by 86% (11 of 154 [7.1%] vs 23 of 150 [15.3%]; P = .02). Twenty-six of the controls (15.5%) and 34 of the intervention patients (20.2%) in the ITT analysis received a recommendation for surgery within 6 months of intervention. However, this difference (30%) did not achieve statistical significance (P = .25). The numbers were very similar when we confined the analysis to the per-protocol sample (24 of 154 controls [15.6%] and 31 of 150 intervention patients [20.7%]; P = .25) (Figure 2 ). Although we did not assess the recommendation for surgery at 12 months, typically patients do not undergo surgery without first receiving a recommendation for surgery from an orthopedic surgeon.
Effects of Study Site
Because the study participants were recruited from 3 different hospital systems in Philadelphia, we examined whether the site of care was related to the effect of the intervention on the recommendation for TKR within 6 months or receipt of TKR within 12 months. We calculated the site-adjusted ORs comparing study arms for the ITT and per-protocol analyses. After adjustment for study site, study findings were essentially identical and we report only results of the site-adjusted analyses. For receipt of TKR at 12 months, the adjusted ORs were 2.10 (95% CI, 1.04-4.27) for the ITT analysis and 2.39 (95% CI, 1.12-5.10) for the per-protocol analysis. For recommendation of TKR at 6 months, the adjusted ORs were 1.39 (95% CI, 0.79-2.44) and 1.41 (95% CI, 0.78-2.55) (Figure 3) .
Subgroup Analysis
For patients who showed a statistically significant increase in the receipt of TKR, we conducted additional exploratory analyses to assess whether particular subgroups of patients might benefit from the intervention to a greater degree than others. The effect of the decision aid intervention on TKR at 12 months was similar among the subgroups (Figure 4) . However, the intervention tended to be more effective than the control treatment for patients aged 50 to 55 years (OR, 4.17; 95% CI, , patients who were willing to undergo surgery at baseline (OR, 2.40; 95% CI, 1.14-5.02), and women (OR, 2.54; 95% CI, 1.03-6.20).
Discussion
In this sample of black patients who were referred to an orthopedic clinic for knee OA, our randomized clinical trial tested Odds ratios (ORs) are shown for the intervention vs control groups at each level of age, sex, Western Ontario McMaster Universities Osteoarthritis Index (WOMAC) score (range, 0-100, with higher scores indicating increased pain, stiffness, and functional limitations), and baseline willingness, adjusted for site. P values for interaction were calculated from logistic regression models including the study group, the covariates and their interaction, and site. Age and WOMAC score were continuous, and baseline willingness was ordinal. The control condition consisted of a booklet about osteoarthritis (OA) of the knee; the intervention, a video examining all treatment options for OA of the knee. ITT indicates intention to treat. the effectiveness of a decision aid for OA of the knee on patients' likelihood of undergoing TKR and/or receiving a recommendation for surgery from an orthopedic surgeon. We found that the decision aid resulted in an 85% increase in the receipt of TKR within 12 months among those who received the intervention compared with controls. The decision aid also increased by about 30% the receipt of a recommendation from an orthopedic surgeon within 6 months of the intervention. However, this association did not achieve statistical significance (P = .25). Finally, we found that the intervention was more likely to lead to surgery among those who at baseline were willing compared with those who were unwilling, for women compared with men, and for patients aged 50 to 55 years compared with older patients. Disparities in TKR represent one of many types of racial and ethnic disparities that exist across various health care conditions and settings. [33] [34] [35] [36] [37] [38] [39] [40] The reasons for these disparities are complex and involve patient-level, physician-level, and system-level factors. One potential etiologic mechanism for disparities in elective treatment such as TKR is patient preference, an attitudinal disposition that is amenable to educational intervention. 41 Patient preference has been reported to vary by race and ethnicity and to influence use of medical care.
42-44
Black patients are less willing to consider joint replacement in general. [45] [46] [47] In a study that examined willingness to pay for TKR among a sample of patients, black and white participants differed significantly in their willingness to pay for TKR, even after adjusting for age, income, educational level, and other factors.
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Although decision aids are used in clinical decision making and are increasingly available for patients' education, their use to reshape patient preference and to empower patients, particularly minority patients in their pursuit of clinical care, is novel and innovative. Decision aids are conceptually framed by decision theories and cognitive behavioral theories 49 and are designed as counseling tools, particularly for preference-sensitive medical conditions or treatments such as TKR. Decision aids provide highquality information on treatment options while also clarifying the outcomes of treatment choice. In this way, they empower patients and facilitate communication and decision making. Decision aids are associated with increased patient knowledge, more realistic patient perceptions about the disease or treatment, less decisional conflict, fewer patients who are passive decision makers, fewer patients who remain indecisive after counseling, and improved concordance between patient values and treatment choices.
50
The National Quality Forum cited shared decision making, which decision aids promote, as one of the 6 health care reforms with the greatest potential to reduce disparities.
51
We used the decision aid in this study as a means to deliver high-quality, relevant, and timely information on OA of the knee and TKR. In contrast to our findings, other studies have examined the use of decision aids as decision tools and found them to be associated with less use of elective invasive surgery such as joint replacement. For example, Arterburn et al 52 published the findings of an observational study that showed decision aids to be associated with reduced use of joint replacement. Similarly, in a Cochrane review, Stacey et al 53 reviewed studies involving the use of decision aids. They found decision aids to be associated with key patient outcomes, such as patient satisfaction with the treatment decision and reduced decisional conflict. In approximately a dozen of those studies, patients were also found to favor conservative treatment compared with major invasive surgery. 53 Our study differs from those studies in that we focused on black patients, who are traditionally skeptical about the use of joint replacement in the management of advanced OA of the knee and hip. The effect of the decision aid on patient access to elective surgery may vary according to where patients are along the treatment preference continuum. The review by Stacey et al 53 indicated that patients with high preference for surgery at baseline might be nudged by the decision aid toward a lower preference for invasive surgery. However, patients who at baseline hold low preference for surgery may be more likely to be moved by the decision aid toward a higher level of preference and possibly higher rates of surgery. One question that our study did not address directly is the mechanism by which the decision aid intervention leads to a higher rate of TKR. However, black patients who are candidates for TKR differ in their preferences for joint replacement, which are primarily shaped by differences in knowledge and understanding about the risks and benefits of the treatment.
22,46 Furthermore, physician-patient communication for preference-sensitive treatments such as joint replacement is bidirectional, and the content of the communication and decisions are influenced by the patient's baseline knowledge and ability to engage in the discussion. Evidence suggests that baseline differences in preference, knowledge, or expectations regarding joint replacement affect the quality of communication between black patients and orthopedic surgeons and consequently reduce black patients' likelihood of receiving a recommendation for joint replacement.
54,55
Limitations Several limitations should be considered in interpreting our results. First, we did not evaluate the nonsurgical treatments our study participants may have received. Various nonsurgical treatment options exist for patients with OA of the knee, including viscosupplementation, intra-articular corticosteroid injections, and medication therapy with various analgesics. 56 Proportions of patients using these OA treatments might have differed by study group at baseline and at any time before the 1-year follow-up, potentially confounding the effects of the intervention on patient treatment preferences. Second, we followed up patients for only 12 months. Given the long-term trajectory of OA of the knee, a longer follow-up may have resulted in a higher rate of surgery among those who received the intervention. Finally, our intervention was brief and occurred only once. A more frequent intervention and better access to a decision aid for patients would result in an even greater likelihood of receiving TKR among those for whom the treatment is clinically appropriate.
Conclusions
In this randomized clinical study of black patients who were referred to orthopedic surgery for OA of the knee, we found that a knee decision aid significantly increased the receipt of TKR within 12 months by 85% compared with those who received the educational pamphlet. The decision aid also increased the likelihood of receiving a recommendation for TKR from an orthopedic surgeon within 6 months of the intervention by 30%. However, this association did not achieve statistical significance. Although the interactions between the study group and the subgroups were not statistically significant, the findings for younger patients, women, and those willing at baseline to benefit more from the decision aid intervention are potentially interesting areas for future investigation. Finally, future research may be needed to also explain the mechanism by which the decision aid actually leads to greater uptake of surgery among black patients and whether this method could be used to address other treatment disparities. 
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Protocol
Abstract A randomized, controlled design will be utilized to examine and compare the effectiveness of the proposed educational intervention, which includes an educational decision aid with attention control on select key patient-centered and process of care outcomes. The study sample will consist of approximately 350 African-American patients with osteoarthritis of the knee. Patients will be recruited from Pennsylvania Presbyterian Medical Center, the Philadelphia VA Medical Center and Temple Orthopaedics & Sports Medicine and will be randomized to one of the two study arms.
Objectives
Overall objectives
The immediate goal of this randomized controlled trial is to assess the effect of a high-quality, evidence-based, patient-centered educational intervention on African American patient preferences, expectations, and the likelihood of receiving a recommendation for knee joint replacement surgery when clinically indicated. The long-term goal of this research is to implement effective strategies to improve minority patients' access to joint replacement and ultimately eliminate racial disparities in the utilization of this effective treatment for knee OA.
Primary outcome variable(s)
Study Aim: To examine the effect of the DA intervention on the likelihood of receiving a recommendation for knee joint replacement when clinically indicated. Hypothesis: The DA intervention will lead to higher rate of treatment recommendation within 6 months. .
Secondary outcome variable(s)
Secondary Aim: To examine the effect of the DA intervention on the rate of knee replacement receipt within 12 months. Hypothesis: Patients randomized to receive the intervention will undergo knee replacement within 12 months at a higher rate than those in the attention control group.
Background 1) Osteoarthritis, epidemiology and impact on health: Osteoarthritis (OA) is the most prevalent form of arthritis and is among the most prevalent chronic conditions in the US. It is estimated that nearly 70 million Americans, about one of every three, are impacted by arthritis or musculoskeletal disease. 2) Knee joint replacement, an effective treatment option for end-stage knee OA: The evidence base for joint replacement as a treatment option for end-stage knee or hip OA has been the subject of several National Institutes of Health (NIH) consensus statements and evidence-based systematic reviews by the Agency for Healthcare Research and Quality (AHRQ). The 2003 NIH consensus statement touted the effectiveness of knee joint replacement. (20) The most recent AHRQ systematic review of over 129 studies found that the evidence supports the effectiveness of joint replacement as the primary surgical option for end-stage knee OA. 3)Evidence of racial/ethnic disparities in the utilization of joint replacement: Numerous studies have documented the existence of racial/ethnic differences in the utilization of knee or hip joint replacement over the past 10-15 years. Most of these studies have utilized Medicare data where access to the procedure based on insurance status is not a significant issue.
Wilson and colleagues studied Medicare hospital claims data from 1980 to 1988 and found that compared to AA men, white men were 3.0 to 5.1 times more likely to undergo knee replacement. Escarce and colleagues examined 1989 Medicare data and found that whites underwent hip replacement three times more often than AAs and were twice as likely to receive knee replacement. McBean and Gornick used the 1992 Medicare database to report an AA to white odds ratio of 0.64 for undergoing knee replacement. 4)Race: A social construct in this research: In this proposal we will use patient selfreported data to determine race, while being consistent with the US Federal government proposed categories of race.However, we recognize the potential problems with the use of racial categories in research and the ongoing scientific debate about the definition of race. We posit that race, as it relates to this area of research, is a social construct and a marker of patient-level cultural and psychosocial factors. Findings from our earlier work in this area support this conceptualization of race. For instance, we found that among potential candidates for joint replacement, AA patients hold different cultural views about knee or hip arthritis care. They also perceive a greater role of religiosity and prayer in knee and hip pain management, and are less knowledgeable about the benefits and risks of joint replacement compared to white patients. In focus group studies of older AA patients with chronic knee or hip arthritis, we also found that AA patients hold culturally-based expectations regarding knee or hip pain and joint replacement. 5)Conceptual framework for this proposal -A theory-based framework for the role of patient preference in treatment seeking: A central hypothesis of this proposal is that cultural and psychosocially based attitudinal factors in combination with contextual factors (i.e., clinical factors) shape patient preferences regarding knee joint replacement, and consequently, the likelihood of seeking and undergoing this procedure if offered. The impact of attitudes on intention (a correlate of preference), and consequently behavior, has been well studied. Most studies that have examined the link between attitudes and intentions and subsequent action (behavior) have been conducted within the framework of the Theory of Planned Behavior and its predecessor, the Theory of Reasoned Action. According to these theories, people act or behave in accordance with their intentions and perceptions of control over their behavior (i.e., self-efficacy). Intentions (e.g., articulated preference for knee joint replacement) are influenced by attitudes toward the behavior or goal (e.g., knee joint replacement as a treatment option) in addition to subjective norms regarding the object or behavior and perception of behavioral control. Examples of practical applications of these theories in public health include use of condoms, smoking cessation, use of hormone replacement therapy, compliance with medications, and use of dental floss. 6)Framework for the proposed intervention: Although the aforementioned theoretical framework provides the scientific basis for the relationship between preference, knowledge and expectancies and how they influence behavior, the intervention component of this proposal operationalizes the conceptual framework. It tests the hypothesis that the knee OA DA will lead to a change in preference by altering patient knowledge and expectancies about joint replacement thus leading to patient empowerment and consequently increasing the likelihood of receiving a recommendation for knee joint replacement when clinically indicated.
Study Design
Phase* Phase I Design Design: A randomized, controlled 2 arm design will be utilized to examine and compare the effectiveness of the proposed intervention, a knee OA decision aid (DA) to attention control on select key patient-centered and process of care outcomes. Methods: We will recruit and conduct the study arm intervention with approximately 350 African-American primary care patients who meet clinical indications for osteoarthritis and randomize them into 1 of the 2 study arms. We will assess patient expectations, willingness and recommendation for knee joint replacement.
Study duration
This study will last 5 years. We anticipate the study to be completed June 30, 2015. Recruitment is to end approximately June 2014. Participants will be be in the study for 1 year.
Resources necessary for human research protection
Describe research staff and justify that the staff are adequate in number and qualifications to conduct the research. Describe how you will ensure that all staff assisting with the research are adequately informed about the protocol and their research related duties. Please allow adequate time for the researchers to conduct and complete the research. Please confirm that there are adequate facilities for the research. Personnel training will be considered to be of the highest priority and will be addressed prior to the start of the trial and on an ongoing basis; it will include training of the Research Assistants, Research Coordinators, and Project Manager on how to interface with the CRCU. The CRCU will train these project personnel to ensure that all processes and procedures for data collection are correctly applied and utilized. All ACTION research staff will complete Human Subjects Training and have been well informed of the procedures and contents of the protocol. In addition, persons who will have access to patient medical records are HIPAA certified. The research staff will have access to subject population at Pennsylvania Presbyterian Medical Center, the Philadelphia VA Medical Center and Temple Orthopaedics & Sports Medicine. Potential participants will be identified with the assistance of Penn's Office of Human Research (PICARD) and with the help of a data manager at the VA's Center for Health
Populations vulnerable to undue influence or coercion none
Subject recruitment
Penn's Office of Human Research and UPHS IT will assist us in identifying potential candidates for this study at Pennsylvania Presbyterian Medical Center using PICARD. A data manager at the PVAMC's Center for Health Equity Research and Promotion office will assist us in identifying potential candidates for this study at the PVAMC. Potential candidates are patients age 50 and over, with knee pain/osteoarthritis (OA). In addition, we will utilize print advertisements to recruit potential candidates at Penn Presbyterian. This advertisement may be published in local print media, or displayed on SEPTA transportation services. Finally we will utilize The Older Adult Research Connection Registry from the Penn Minority Aging Research Center for Community Health. The Older Adult Research Connection Registry is a database of research participants who are 55 and older, and have expressed an interest in being contacted by other researchers at The University of Pennsylvania. Participants recruited through study advertisements or the Older Adult Research Connection Registry will be screened to ensure they are patients within the University of Pennsylvania Health System. We will then check medical charts to look for a knee x-ray showing OA, and the reason for the orthopedic specialist appointment. We are requesting a waiver of HIPAA in order to identify potentially eligible patients. We will then mail letters to these patients to all of these patients requesting permission to contact them about the study via telephone. Patients who have e-mail addresses as part of their EMR will additionally receive this recruitment letter via e-mail. Those who do not opt out will be called by our research staff and assessed for study eligibility after a brief verbal consent process for screening and completion of the baseline telephone interview. Potentially eligible participants will be mailed a consent form to sign and return. If they do not have an x-ray on file with UPHS, we would ask them to mail us the report from a knee xray from another health system. After confirmation of radiographic eligibility, eligible patients will then be administered the baseline assessments by telephone. The hospital staff will not have any responsibilities for screening or intervening. All study tasks will be conducted by project-supported staff. In addition, data will be collected by the study staff from medical records and from surveys when we meet/call patients. If there is subject compensation, provide the schedule for compensation per study visit or session and total amount for entire participation, either as text or separate document
A total of $50 will be paid to the participant for completing all parts of the study (the screening, baseline, educational intervention, and 12-month follow-up.) The breakdown of payments are as follows: 1) $30 will be paid to the participant upon completing the educational intervention 2) an additional $20 will be paid to the participant upon completing the 12 month follow-up questionnaire over the phone.
Study Procedures
Suicidal Ideation and Behavior Does this research qualify as a clinical investigation that will utilize a test article (ie-drug or biological) which may carry a potential for central nervous system (CNS) effect(s)? No
Procedures
Eligible individuals who provide verbal consent to participate in the study will undergo the same screening procedures utilized in our previous and ongoing observational studies of similar patient populations. (Screening form attached.) They will complete a brief screening questionnaire to confirm the presence of chronic, frequent knee pain and rate pain severity and functional limitations. The Arthritis Supplement National Health and Nutrition Examination Survey will be used to identify the presence of chronic, frequent knee pain. This survey assesses the presence of pain in the knee on at least half of the days over the past month, and pain in either knee for more than 6 months. Potential subjects that answer yes to both questions will be categorized as having chronic, frequent knee pain. Individuals that screen positive for chronic, frequent knee pain using the above questions will then proceed to the next phase of screening which uses the WOMAC index. Only individuals with moderate to severe chronic knee pain as defined by WOMAC index will be eligible for enrollment. The WOMAC scale is validated and reliable. We have used this scale for screening patient into our previous studies and works well. A score of greater than 39 is considered severe enough for consideration of surgical referral.
Patients who score less than 39 will not be eligible for the study. They will also be asked to self-identify race/ethnicity at that time. We field-tested our screening process in prior studies and it takes 10 minutes to determine if a patient is a potential candidate for the study. To assess for radiographic eligibility, we will view patients existing knee x-ray. We will look at the x-ray report for signs of osteoarthritis. Knee radiograph reports documenting osteophytes with joint space narrowing, bony sclerosis, or possible deformity of bone ends or simply osteoarthritis will be considered radiographic confirmation of OA. Consistent with our original strategy, we will randomize only patients with radiologic evidence of knee OA.
(1) age 50 or over; (2) chronic frequent knee pain; and (3) radiographic evidence of OA as defined above. These are the same criteria used in our previous study. Patients will be given a verbal consent prior to screening and baseline interview. If the patient is found to be eligible according to the screening and baseline survey and radiographic confirmation, they will be sent an informed consent to read and sign. We will track recruitment on an ongoing basis by calculating the number of patients approached, number who meet criteria, number who consent to enroll, and number randomized weekly. For those eligible patients who are not enrolled, we will assess and record reasons for non-enrollment. This recruitment strategy will be assessed periodically to make necessary adjustments. Eligible patients will be randomized to either the DA intervention arm or the attention control arm. Once eligibility for randomization has been determined and consent obtained, the study coordinator will be informed. The study coordinator will notify the statistician that a patient is eligible and the data manager will then generated random assignment to one of the two study arms (intervention vs. attention control). The study coordinator will notify the interventionist of the treatment assignment. The randomization schedule will be developed according to standard randomization procedures by the study statistician. Once a patient is randomized, that patient will be included in the intention to treat analysis. Once the patient is randomized, they will be asked to complete the Baseline Survey. This can occur over the phone or in person. (Baseline survey attached.) Subjects randomized to the attention control arm will receive an educational program (an NIH-developed booklet) that summarizes how to live with knee OA but does not specifically mention joint replacement. (Booklet is attached.) This booklet provides information about OA, examples of exercises one could do to improve pain and reduce stiffness, types of non-drug pain relief such as massage, and information about various medications. The interventionist will give the participant the booklet and describe what can be found inside. They are also encouraged to ask their doctor any questions they may have about the information in the booklet or questions they may have about their OA. The purpose of this educational program is to provide a tangible clinical incentive to the control group for participating in this additional component of the study. The intervention and attention control treatments will both be administered in the clinic at the study site. We have given a careful consideration to minimize differences in the treatment experience between the attention control arm and the DA intervention arm. Patients in both arms undergo identical screening procedures and baseline assessments. Patients randomized to the attention control arm will then receive the attention control educational booklet, instead of the DA intervention. Patients randomized to the DA Intervention will watch a Knee OA Decision Aid (DA) developed by the Foundation for Informed Medical Decision Making and then receive a brief counseling session called "AskMe3." The DA is a video that provides viewers with information about OA, treatment choices such as lifestyle changes, non-drug treatments, medication, injections, complementary therapies, and surgery, as well as the pros and cons of each type of treatment. The AskMe3 is a communication skill-building intervention, which instructs patients to ask 3 questions to the doctor: 1) What is my main problem? 2) What do I need to do? 3) Why is it important for me to do this?. Interactions and assessments with the attention control arm and the DA intervention arm from this point forward will be identical. At 6 months postintervention, all of the patient's medical charts will be reviewed for evidence of knee joint replacement surgery. At 12 months post-intervention, all patients in both arms will undergo a survey over the phone and an assessment of the primary study outcome; receipt of joint replacement.
The following documents are currently attached to this item:
Deception
Does your project use deception? No
Analysis Plan
The analyses plan will focus on the impact of the DA intervention on study outcomes using the original treatment assignment as randomized for each participant regardless of compliance (intent-to-treat). Statistical methods will control for the study site and the clustering of patients within providers. We propose enrolling and randomizing 350 participants to DA intervention or control. Analyses will be done using SAS version 9.1.3. We will first compare the distribution of baseline prognostic factors between participants the DA and control groups to assess the effectiveness of the randomized allocation. Continuous variables will be graphed using histograms to determine symmetry of their distributions and identify any potential outliers. Variables with fairly symmetric distributions will be summarized using means and standard deviations. Those with highly skewed distributions will be described using medians and interquartile ranges. In addition, some may be categorized to facilitate their use in further analyses. Categorical data will be summarized using frequencies and percentages. Any baseline prognostic factors that are meaningfully imbalanced between the two groups will be controlled for in secondary analyses testing the intervention effects. The research team will make extensive efforts to collect complete information on each subject enrolled in the study. Participants will be randomized before they arrive for their appointment with the orthopaedic surgeon. The primary type of dropout may occur before randomization if the participant does not complete the baseline survey. This type of dropout will not affect our study results because the participants will not have been randomized. Once they arrive for the visit, they will receive the intervention or control just before their appointment with the surgeon. Missing data for the 6 month referral outcome should be minimal (1%) due to the nature of the data collection via chart abstraction. Missing data are most likely to occur for the 12 month knee replacement outcome which will be assessed via telephone interview with the participant and verification by medical chart review. Our experience indicates that up to 10-20% of subjects who initially enroll may be lost to follow-up; because 12 month knee replacement is a secondary exploratory outcome, we have not adjusted our sample size for this attrition. The analyses will be intent-to-treat in that, to the extent possible, all randomized patients will be included in the analyses regardless of receipt of the appropriate intervention or loss to follow-up. Patients who are lost to follow-up may be missing key outcomes or measures that may prevent inclusion in some analyses. Furthermore, in our analysis we will compare the characteristics of participants who are lost to followup with those who complete the study as well as if there are differences by treatment arm. Primary specific aim: To examine the effect of the DA intervention on the likelihood of receiving a recommendation for knee joint replacement when clinically indicated . Secondary aim: To examine the effect of the DA/MI intervention on the rate of knee replacement receipt within 12 months. Recommendation of knee joint replacement 6 months after intervention will be assessed for all patients by chart abstraction. Receipt of knee joint replacement will be assessed for all patients 12 months postintervention initially through telephone survey and then validated by medical record review. These outcomes are dichotomous (present or not present). We will first calculate the unadjusted percentages of each by DA and control groups. We will then use logistic regression to analyze each outcome controlling for the clustering within provider using GEE. Results will be presented using frequencies, percentages, odds ratios, and adjusted 95% confidence intervals.
The following documents are currently attached to this item:
Are you conducting research outside of the United States? No
Data confidentiality
x Paper-based records will be kept in a secure location and only be accessible to personnel involved in the study.
x Computer-based files will only be made available to personnel involved in the study through the use of access privileges and passwords.
x Prior to access to any study-related information, personnel will be required to sign statements agreeing to protect the security and confidentiality of identifiable information.
x Wherever feasible, identifiers will be removed from study-related information.
A Certificate of Confidentiality will be obtained, because the research could place the subject at risk of criminal or civil liability or cause damage to the subject's financial standing, employability, or liability.
x A waiver of documentation of consent is being requested, because the only link between the subject and the study would be the consent document and the primary risk is a breach of confidentiality. (This is not an option for FDA-regulated research.)
x Precautions are in place to ensure the data is secure by using passwords and encryption, because the research involves web-based surveys.
x Audio and/or video recordings will be transcribed and then destroyed to eliminate audible identification of subjects.
Subject Confidentiality
This study utilizes several methods to protect patient privacy. First and foremost the collection of sensitive information about subjects is limited to the amount necessary to achieve the specific aims of the research, so that no unneeded sensitive information is being collected. Second, all hard copies of patient data (i.e. informed consents) are kept in locked drawers which reside in locked rooms. Only approved research staff, meaning staff that has obtained certificates in good clinical practice and that have signed confidentiality agreements, have access to these files. Third, all digital patient data is kept on password protected computers on University protected servers at Penn the PVAMC and Temple Hospital. Patient data is stored on encrypted local hard drives that are password protected. Only approved staff are granted access to digital files. Furthermore, identifiers will be removed from studyrelated information. Finally, all research staff is educated in the rules of patient confidentiality and protection. No research staff would ever share any information with outside persons. At the conclusion of the study all study data from the PVAMC and Temple Hospital will be deindentified and then transferred to Penn via CD media for study analysis.
Sensitive Research Information* Does this research involve collection of sensitive information about the subjects that should be excluded from the electronic medical record? No
Subject Privacy
Privacy refers to the person's desire to control access of others to themselves. Privacy concerns people, whereas confidentiality concerns data. Describe the strategies to protect privacy giving consideration to the following: The degree to which privacy can be expected in the proposed research and the safeguards that will be put into place to respect those boundaries. The methods used to identify and contact potential participants. The settings in which an individual will be interacting with an investigator. The privacy guidelines developed by relevant professions, professional associations and scholarly disciplines (e.g., psychiatry, genetic counseling, oral history, anthropology, psychology). This study utilizes several methods to protect patient privacy. First and foremost the collection of sensitive information about subjects is limited to the amount necessary to achieve the specific aims of the research, so that no unneeded sensitive information is being collected. Second, all hard copies of patient data (informed consents) are kept in locked drawers which reside in locked office rooms. 
Consent
Consent Process
Overview A waiver of HIPAA in order to identify potentially eligible patients is requested. A waiver to obtain signed informed consent has been requested for completion of the screening and baseline interview in addition to the review of patients medical record to screen further for eligibility. This waiver will only be applicable to Penn Presbyterian patients. A waiver to obtain signed informed consent was approved by the PVAMC IRB for completion of the screening, however the baseline and intervention cannot be conducted until the PVAMC patient receives and signs the written informed consent and HIPAA authorization. Patients will be informed of staff contact information, that their participation is completely voluntary, that they may withdraw at any time and that the verbal consent applies only to the screening and baseline interview and review of medical record for Penn Presby patients and applies only to the screening and medical review for PVAMC patients. Following completion of the verbal consent, screening (and baseline interview for Penn Presby patients only) and review of patients medical record, research staff will complete written informed consent which contains further details about the study with patients. They will be given the opportunity to read the informed consent, ask questions, and return it signed at their convenience. They will also be encouraged to call with any questions. We will also remind them that this study is completely voluntary and that they would not lose any benefits by choosing not to participate.
Children and Adolescents Not Applicable
Adult Subjects Not Competent to Give Consent
All adult subjects will be competent to give consent.
Waiver of Consent
Waiver or Alteration of Informed Consent* Waiver of written documentation of informed consent: the research presents no more than minimal risk of harm to subjects and involves no procedures for which written consent is normally required outside of the research context 
Risk / Benefit
Potential Study Risks
There is minimal risk in this study. The primary risk of participation is loss of confidentiality. The investigators have considerable experience in handling confidential patient information and minimizing the risk of loss of confidentiality. All patient information will be de-identified whenever possible and kept in password protected and or locked files.
Potential Study Benefits
Each participant may benefit directly by gaining knowledge about treatment options that are available for patients with knee pain. Both the control arm and the intervention arm offer information about treatment options that are currently available for people with knee pain.
Alternatives to Participation (optional)
Data and Safety Monitoring A data and safety monitoring plan will be implemented to ensure that there are no changes in the risk/ benefit ratio during the study and that confidentiality of research data is maintained. Investigators and study personnel will meet at least monthly to discuss issues like study progress, modifications, documentation, recruitment, retention, data analysis and confidentiality and to address any issues or concerns at the time. The CRCU database administrator will be responsible for preventing unauthorized access to the trial database. The CRCU database server and study databases have never been compromised as a result of extremely rigorous and secure network firewall technologies. The secure servers are located in a specially designed, highly secured UPENN facility with dedicated uninterrupted power supply and strictly limited access. In addition if a subject decides to withdraw from study participation, the research data collected from that subject will be rendered anonymous. Depending on what data was collected from the patient, his/her data may or may not be used in analysis. A data safety monitoring plan will be implemented at the PVAMC to ensure that there are no changes in the risk/ benefit ration during the study and that confidentiality of research data is maintained. The PI and study personnel will meet regularly to discuss any issues like study progress, modifications, documentation, recruitment, retention, data analysis and confidentiality and to address any issues or concerns at the time. The database administrator will be responsible for preventing unauthorized access to the trial database. All information will be stored on PVAMC computers with secure servers in a PVAMC facility. All PVAMC patient information will be storied in protected files on a PVAMC secure network. Study data will be stored on the CHERP's Network Attached Storage (NAS) server (with a single 3Ghz Intel Xeon Processor, Microsoft Windows Server 2003 Enterprise Edition operating system, 1Gb RAM, and 2.7TB Internal RAID) which is also password protected. Administrative and technical measures are in place to restrict access to the study data. These servers reside in the PVAMC IT server room (room #A001). Additionally, these servers are networked within the VA firewall to provide the same level of data security as other VA patient care information systems. Our research assistant, Sr. Coordinator, and Interventionist will go through PVAMC training and authorization. All information will be stored securely and only shared with trained study team members. In addition, if a subject decides to withdraw from study participation, the research data collected from the subject will be rendered anonymous. Depending on what data was collected from the patient, his/her data may or may not be used in analysis. A data safety monitoring plan will be implemented at Temple Orthopaedics & Sports Medicine to ensure that there are no changes in the risk/benefit ration during the study and that confidentiality of research data is maintained. The PI and study personnel will meet regularly to discuss any issues like study progress, modifications, documentation, recruitment, retention, data analysis and confidentiality and to address any issues or concerns at the time. The database administrator will be responsible for preventing unauthorized access to the trial database. All information will be stored on Temple Orthopaedics & Sports Medicine computers with secure servers in a Temple Orthopaedics & Sports Medicine facility. All Temple Orthopaedics & Sports Medicine patient information will be storied in protected files on a Temple Orthopaedics & Sports Medicine secure network. Our research assistant, Sr. Coordinator, and Interventionist will go through Temple Orthopaedics & Sports Medicine training and authorization. All information will be stored securely and only shared with trained study team members. In addition, if a subject decides to withdraw from study participation, the research data collected from the subject will be rendered anonymous. Depending on what data was collected from the patient, his/her data may or may not be used in analysis. At the conclusion of the study all study data from the PVAMC and Temple Hospital will be deindentified and then transferred to Penn via CD media for study analysis.
The following documents are currently attached to this item:
Risk / Benefit Assessment
There is minimal risk in this study and direct benefit to the patient. The primary risk of participation is loss of confidentiality. The investigators have considerable experience in handling confidential patient information and minimizing the risk of loss of confidentiality. All patient information will be deidentified and kept in password protected and or locked files. On the other hand, each participant may benefit directly by gaining knowledge about treatment options that are available for patients with knee pain. Both the control arm and the intervention arm offer information about treatment options that are currently available for people with knee pain.
